Document Type

Article

Publication Date

3-1-2020

Publication Title

Open Forum Infect Dis

Abstract

Fourty patients were treated with meropenem-vaborbactam (MEV) for serious Gram-negative bacterial (GNB) infections. Carbapenem-resistant Enterobacteriaceae (CRE) comprised 80.0% of all GNB infections. Clinical success occurred in 70.0% of patients. Mortality and recurrence at 30 days were 7.5% and 12.5%, respectively. One patient experienced a probable rash due to MEV.

PubMed ID

32161775

Volume

7

Issue

3

First Page

051

Last Page

051

Share

COinS